Skip to main content

BioSig Technologies, Inc. (BSGM)

NASDAQ: BSGM · IEX Real-Time Price · USD
3.03 0.00 (0.00%)
Sep 23, 2021 4:00 PM EDT - Market open
Market Cap106.17M
Revenue (ttm)325,000
Net Income (ttm)-37.72M
Shares Out34.92M
EPS (ttm)-1.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,946
Open-
Previous Close3.03
Day's Range2.83 - 3.04
52-Week Range2.67 - 6.14
Beta1.75
AnalystsBuy
Price Target13.00 (+329.0%)
Est. Earnings DateNov 4, 2021

About BSGM

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial...

IndustryHealth Care Equipment & Supplies
Founded2009
Employees49
Stock ExchangeNASDAQ
Ticker SymbolBSGM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for BSGM stock is "Buy" and the 12-month stock price forecast is 13.00.

Price Target
$13.00
(329.04% upside)
Analyst Consensus: Buy

News

BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients

Image by PublicDomainPictures from Pixabay  An estimated 33.5 million individuals worldwide and nearly 2.7 million people in the U.S. live with an often silent, untreated medical issue.

23 hours ago - Benzinga

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing technology for arrhythmia care James J. Barry, Ph.D. will join as an Independe...

2 days ago - GlobeNewsWire

BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation

Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing one of its new PURE EP systems in St. Elizabeth's Medical Center in Bos...

1 week ago - Benzinga

4 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...

Other symbols:BTTRGRILPHX
3 weeks ago - Benzinga

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Sy...

Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Physician-only event, organized by the University of Pennsylvania, is a tribut...

3 weeks ago - GlobeNewsWire

BioSig's Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium

A physician user from a leading medical center of excellence will present the technology and discuss recent clinical data A physician user from a leading medical center of excellence will present the te...

1 month ago - GlobeNewsWire

BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annu...

Confirmed speakers include the largest technology users from Mayo Clinic, Texas Cardiac Arrhythmia Institute, and University of Pennsylvania Confirmed speakers include the largest technology users from ...

2 months ago - GlobeNewsWire

BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology

Texas installation builds as company adds team members to support installations around major metropolitan areas Texas installation builds as company adds team members to support installations around maj...

2 months ago - GlobeNewsWire

BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmi...

Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

2 months ago - GlobeNewsWire

BioSig Announces Closing of Public Offering of Common Stock

Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal process...

2 months ago - GlobeNewsWire

BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology

The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence The Company installs its novel medical technology platform for arrhythmia care in a leadi...

2 months ago - GlobeNewsWire

Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location

According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the evalu...

2 months ago - Benzinga

BioSig Technologies Raises $10M Via Equity Issued At $4/Share

BioSig Technologies Inc (NASDAQ: BSGM) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share, representing a discount of 8% from the last close price ...

2 months ago - Benzinga

BioSig Announces Pricing of Public Offering of Common Stock

Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal process...

2 months ago - GlobeNewsWire

BioSig Announces Proposed Public Offering of Common Stock

Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) --   BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proce...

2 months ago - GlobeNewsWire

BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021

According to recent reports, the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by 2026, at a compound annual growth rate (C...

2 months ago - Benzinga

BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology

Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proces...

2 months ago - GlobeNewsWire

BioSig's Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhyth...

Presentation to highlight clinical applications of the Company's latest software for arrhythmia care Presentation to highlight clinical applications of the Company's latest software for arrhythmia care

2 months ago - GlobeNewsWire

BioSig's Signal Processing System for Electrophysiology Featured in Two Clinical and Scientific Presentations during ...

Abstracts are due to be presented by physician users and research investigators from two leading institutions Abstracts are due to be presented by physician users and research investigators from two lea...

3 months ago - GlobeNewsWire

BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event

Presentation on Tuesday, June 8, 2021, at 5 PM ET Presentation on Tuesday, June 8, 2021, at 5 PM ET

3 months ago - GlobeNewsWire

BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference

Westport, CT, May 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform...

3 months ago - GlobeNewsWire

BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform...

4 months ago - GlobeNewsWire

BioSig Technologies looking to unlock the future of bioelectronic medicine

Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform called ...

4 months ago - Proactive Investors

BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System

The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases t...

4 months ago - Benzinga